32nd Biennial Cornea Conference

第32届双年度角膜会议

• 批准号: 10539749
• 负责人: ILENE K. GIPSON
• 金额: $ 2.5万
• 依托单位: SCHEPENS EYE RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-09-01 至 2023-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10539749
• 关键词: American; Anterior; Area; Award; Basic Science; Blindness; Boston; Charge; Clinical Research; Collaborations; Cornea; Corneal Diseases; Development; Diagnosis; Disease; Doctor of Philosophy; Ear; Electronic Mail; Endothelium; Environment; Eye; Eye diseases; Face; Faculty; Failure; Feedback; Fostering; Functional disorder; Funding; Goals; Graft Rejection; Immune; Immunologics; Immunology; Keratitis; Laboratory Research; Lead; Massachusetts; Methods; Microbiology; Names; Ophthalmology; Oral; Pathogenesis; Pathologic; Physicians; Quality of life; Regenerative Medicine; Reporting; Research; Research Institute; Research Personnel; Science; Scientist; Senior Scientist; Societies; Surveys; Time; Transplantation; Travel; Universities; Vision; Visual impairment; Work; age group; aging population; design; endothelial dysfunction; eye dryness; graduate student; improved; innovation; insight; lectures; medical schools; meetings; member; microbial; mid-career faculty; multidisciplinary; new technology; next generation; ocular surface; posters; prevent; professor; programs; skills; success; symposium; translational applications; transplantation medicine

Abstract Funds are requested to support trainee participation at the 32nd Biennial Cornea Conference to be held at Schepens Eye Research Institute of Massachusetts Eye and Ear on October 21-22, 2022. The program for the conference was developed by the co-chairs, Dr. Ilene Gipson, PhD, Professor Emeritus at Harvard Medical School, Dr. Ula Jurkunas, MD, Associate Professor of Ophthalmology at Harvard Medical School, Dr. Reza Dana, MD, MPH, Claes H. Dohlman Professor of Ophthalmology at Harvard Medical School, and an organizing committee of eleven experts in the field of Cornea from Harvard, Tufts, and Boston University Medical Schools. The program builds on the success of the previous 31 conferences, first started in the 1960s. Despite advancements in the field, corneal disease and blindness remain common causes of vision loss and impairment worldwide and across all age groups. It is imperative to better understand the mechanisms behind corneal disease development and to develop new methods of diagnosis and treatment. The goals of this conference are to create an opportunity for discussion and for the formation of collaborations aimed at elucidating the mechanisms that underlie the development of various ocular surface and corneal diseases, and to provide trainees in the field an opportunity to present their research and meet leaders in the field. Sessions on the ocular surface, immunologic and microbiologic aspects of corneal disease, as well as discussions on the endothelium and regenerative medicine & transplantation are planned. After receiving positive feedback from the 31st Biennial, an additional panel has been added to the program. Though panelists are still being determined by the committee, panel discussions on areas of greatest unmet need in cornea, controversies in corneal pathobiology, and innovation & new technologies have been planned. A unique feature of this small conference is the ample time allowed for discussion after each speaker presentation, as well as ample time for dedicated poster sessions highlighting trainee research. We anticipate at least 70 poster presentations that will allow trainees the opportunity to present their research to all conference attendees, receive immediate feedback, and engage leading experts in cornea in conversation over their work. As is tradition, the conference honors an accomplished physician scientist and a scientist with the two named lectures. Dr. Stefano Bonini, MD, will give the Claes H. Dohlman Lecture and Dr. Arlene Sharpe MD, PhD, will give the J. Wayne Streilein Lecture. The anticipated attendance for the conference is 250 physicians, scientists, and trainees. We intend to provide travel awards to attract graduate students and fellows and will make every attempt to make the conference free of charge for all trainees.

抽象的 请求资金支持学员参加将于以下地点举行的第 32 届双年度角膜会议 2022 年 10 月 21 日至 22 日，马萨诸塞州眼耳科谢彭斯眼科研究所 (Schepens Eye Research Institute of Massachusetts Eye and Ear)。 会议由联合主席、哈佛医学院名誉教授艾琳·吉普森博士发起 学校，Ula Jurkunas 博士，医学博士，哈佛医学院眼科副教授，Reza 博士 Dana，医学博士、公共卫生硕士，哈佛医学院 Claes H. Dohlman 眼科教授， 组委会由来自哈佛大学、塔夫茨大学和波士顿大学的 11 名角膜领域专家组成 医学院。该计划以 20 世纪 60 年代首次启动的前 31 次会议的成功为基础。 尽管该领域取得了进步，但角膜疾病和失明仍然是视力丧失和失明的常见原因。 全世界所有年龄段的损伤。必须更好地理解背后的机制 角膜疾病的发展并开发新的诊断和治疗方法。本次活动的目标 会议的目的是创造一个讨论和形成合作的机会，旨在 阐明各种眼表和角膜疾病发生的机制，以及 为该领域的学员提供展示其研究成果并会见该领域领导者的机会。会议 关于角膜疾病的眼表、免疫学和微生物学方面，以及关于 内皮细胞、再生医学和移植正在计划中。收到积极反馈后 从第31届双年展开始，该项目增加了一个额外的小组。尽管小组成员仍在 由委员会决定，针对角膜中最未满足需求的领域进行小组讨论， 角膜病理学、创新和新技术已经规划。这个小装置的独特之处在于 会议是指在每次演讲者发言后留出足够的时间进行讨论，以及 专门的海报会议强调实习生研究。我们预计至少有 70 场海报展示 让学员有机会向所有与会者展示他们的研究成果，立即获得 反馈，并让角膜领域的领先专家就他们的工作进行对话。按照惯例，会议 表彰一位有成就的医师科学家和一位通过两次命名讲座的科学家。斯特凡诺·博尼尼博士， 医学博士，将进行 Claes H. Dohlman 讲座，Arlene Sharpe 博士将进行 J. Wayne Streilein 讲座 演讲。预计出席会议的人数为 250 名医生、科学家和实习生。我们打算 提供旅行奖励以吸引研究生和研究员，并将尽一切努力使 会议对所有学员免费。